awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36263943-2C89CB12-639E-4B87-9B49-F75D3FBE4050
Q36263943-2C89CB12-639E-4B87-9B49-F75D3FBE4050
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36263943-2C89CB12-639E-4B87-9B49-F75D3FBE4050
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
P2860
Q36263943-2C89CB12-639E-4B87-9B49-F75D3FBE4050
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36263943-2C89CB12-639E-4B87-9B49-F75D3FBE4050
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d463017f33c458554bc4e644f4345eaadf0305d
P2860
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia.